abstract |
An immunogenic conjugate useful as a vaccine against infection with Haemophilus influenzae is provided. A synthetic ribose ribitol phosphate (PRP) oligomer is produced by polymerization in a solid phase / liquid phase system, and a synthetic peptide containing at least one T cell peptide is bound to the resulting PRP oligomer for immunization. A protogenic conjugate is obtained. [Selection figure] None |